F. Hoffmann-La Roche Ltd (Roche) is a healthcare company that develops drugs and diagnostics devices for treating diseases. It provides medicine and diagnostics for oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory, and other areas. The company also provides in-vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers, and pharmacists. The company, along with its subsidiaries, has operations across the Americas, Europe, Asia, Africa, and Oceania.
The report provides information and insights into Roche's tech activities, including:
- Insights of its digital transformation strategies and innovation programs.
- Overview of technology initiatives covering partnerships and product launches.
- Insights on each technology initiative including technology theme, objective, and benefits.
- Details of estimated ICT budgets and major ICT contracts.
Scope
- The report provides insights into company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Reasons to Buy
- Gain insights into Roche's tech operations.
- Gain insights into its tech strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into various product launches and partnerships.
Table of Contents
- Overview
- Digital Transformation Strategy
- Accelerators, Incubators, and Innovation Programs
- Technology Focus
- Technology Initiatives
- Venture Arm
- Investments
- Acquisitions
- Partnership, Investments & Acquisition Network Map
- ICT Budget
- Key Executives
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Nye Health
- Recursion
- PathAI
- Ibex Medical Analytics
- Genesis Therapeutics
- Sensyne Health
- Medial EarlySign
- AWS
- SAP
- Novo Nordisk
- Microsoft
- Prescient Design
